Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Nov 13 - Nov 18
International journal of molecular medicine, 44(1), 315
Cognitive behavioral therapy remains the first-line treatment with the strongest evidence base
Statistical significance was assessed by by ordinary two-way ANOVA in a , and by unpaired two-tailed t-test in b , c
Last reviewed: June 20, 2026 Last updated: June 20, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
We observed a lower risk of a composite primary end-point event with tirzepatide than with placebo over a median of 2 years, in particular with respect to fewer worsening heart-failure events resulting in hospitalisation or use of intravenous drugs in an urgent care setting, the researchers said in the NEJM
